<DOC>
	<DOCNO>NCT00777374</DOCNO>
	<brief_summary>Seasonal rhinoconjunctivitis hay fever common atopic condition frequently see clinical practice . Grass pollen major cause pollinosis many part world . Immunotherapy treatment may affect natural course allergic disease , may also prevent development asthma patient allergic rhinitis . With conventional subcutaneous desensitization duration treatment around 3-5 year usually comprise around 30-100 allergen injection . As high allergen dos inject , allergic side effect may occur patient must stay medical supervision least 1 hour . Transcutaneous immunization ( TCI ) needle -free technique delivers antigens adjuvant potent epicutaneous immune cell . The aim new epicutaneous route desensitization specifically target immune system load Langerhans cell allergen . Lower antigen dos apply , side effect reduce .</brief_summary>
	<brief_title>Study Specific Allergen Immunotherapy Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>Inclusion criterion : Written inform consent History grass pollen allergic rhinitis least two year Male female 18 year 65 year Positive skinprick test grass pollen Positive conjunctival provocation test Exclusion criterion : Eczematous skin lesion upper arm Perennial rhinitis due perennial allergy anatomical reason ( polyp , septal deviation ) Symptoms infectious disease rhinitis last week Surgical intervention last 30 day Pregnancy nurse History HIV AIDS History mastocytosis ( cutaneous systemic ) History significant cardiovascular disease Uncontrolled Hypertension ( blood pressure &gt; 160 / 95 ) History significant pulmonary , renal and/or hepatic disease History significant hematological disorder Moderate severe asthma History malignancy Significant neurological psychatric disease History active autoimmune disease Antihistamines long halflives last week Systemic topical steroid 5 day Depot corticosteroid last two month Active infectious disease Adipositas per magna Contraindicated medication : immunosuppressive agent Betablockers ACEinhibitors , AT 2 Antagonists tricyclic antidepressant daily use Betaagonists steroid inhaler Participation another clinical trial /study moment within last 60 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>